Status:
COMPLETED
PSG and Neuroendocrine Hormones in Subjective Cognitive Impaired Patients With Transformed Migraine
Lead Sponsor:
Mansoura University Hospital
Conditions:
Migraine
Eligibility:
All Genders
18-65 years
Brief Summary
Transformed migraine is the most common and challenging subtype of chronic daily headache disorders35. Patients with transformed migraine often report an evolutionary process that occurs over months o...
Detailed Description
The present study aimed to investigate the presence and frequency of cognitive affection in patients with transformed migraines, as well as to analyze the association of cognitive affection with clini...
Eligibility Criteria
Inclusion
- Patients included were adults with clinically confirmed of chronic migraine
Exclusion
- Primary headache disorder other than migraine
- Secondary headache disorders other than medication-overuse headache or unclassified headache, or
- Aged under 18 years or older than 65 years
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
161 Patients enrolled
Trial Details
Trial ID
NCT04413110
Start Date
April 1 2019
End Date
April 1 2020
Last Update
June 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University Hospital
Al Mansurah, Dakahlia Governorate, Egypt, 35516